Methinks Software S.L.

Pier01, Office 2D2, Plaça de Pau Vila 08039 Barcelona, Spain  All Spain companies → — Founded 2016
Imaging AI Specialist Specialty-Focused AI
Emergency Medicine Neurology Radiology
Neurology AI Radiology & Imaging AI Triage & ER/ICU AI
Venture Capital-Backed — Approximately €12.19 million (€3.3 million in public grants and €6.7 million in private investment, plus a recent €2.19 million for the Neuro-rescue project)

Products

Methinks NCCT Stroke
Methinks Software S.L.
Neurology AI
Methinks NCCT Stroke is an FDA-cleared AI software that detects suspected Large Vessel Occlusions (LVOs) and intracranial hemorrhages (ICH) on non-contrast CT scans, enabling rapid stroke triage and improving patient outcomes.
Methinks CTA Stroke
Methinks Software S.L.
Neurology AI
Methinks CTA Stroke is an FDA-cleared AI software that accurately detects suspected large vessel occlusions (LVOs) from CTA scans, including distal occlusions, with high sensitivity and specificity. It integrates with hospital systems and Microsoft Teams for real-time stroke triage and team coordination.

See all 2 products →

About Methinks Software S.L.

Methinks Software S.L. is a healthcare AI company dedicated to transforming acute stroke care through advanced medical imaging software. Their flagship “Methinks Stroke Suite” leverages artificial intelligence algorithms to rapidly detect suspected Large Vessel Occlusions (LVOs) and intracranial hemorrhages (ICH) on both routine non-contrast Computed Tomography (NCCT) scans and CT angiography (CTA) images. This technology is particularly valuable in resource-limited environments where access to advanced imaging might be constrained, facilitating earlier and more precise diagnoses.

For physicians, Methinks’ solution serves as a crucial tool to streamline stroke triage and accelerate critical treatment decisions. The AI-powered software seamlessly integrates with existing hospital workflows, including platforms like Microsoft Teams, to deliver real-time alerts and enhance communication among stroke teams and healthcare professionals. By enabling swift and accurate identification of LVOs and hemorrhages, Methinks aims to significantly reduce the time from stroke onset to intervention, thereby improving patient outcomes and mitigating long-term disability. The company has secured FDA 510(k) clearance for its NCCT Stroke and CTA Stroke software, and a CE mark for its Stroke Suite, underscoring its validated efficacy and safety for clinical application.

What Physicians Need to Know

Specialization: Stroke AI
Methinks Software S.L. specializes in AI-powered solutions for the early assessment and triage of stroke, focusing on detecting Large Vessel Occlusions (LVOs) and intracranial hemorrhages (ICH) from medical imaging.
Key Differentiator: Non-Contrast CT Capability
Their software can detect LVOs and ICH from standard, non-contrast CT (NCCT) scans, making advanced stroke assessment accessible even in hospitals without specialized imaging equipment.
Key Differentiator: Distal LVO Detection
Methinks stands out by accurately detecting not only large, proximal LVOs but also subtle, distal occlusions (e.g., in the MCA-M2 segment) with high sensitivity and specificity, which are frequently overlooked by other tools.
Key Differentiator: High Accuracy & Speed
The solution has demonstrated high accuracy, detecting over 80% of suspected LVOs with a simple CT scan and an error rate of less than 15% in cases without occlusion, showing 45% higher accuracy than radiologists in some instances. It provides alerts with an average notification time of one minute and 27 seconds.
Technology Stack: Cloud & AI
The solutions are built on AI algorithms, run on Microsoft Azure, and leverage cloud technology for real-time alerts and scalability.
Technology Stack: Microsoft Teams Integration
Methinks seamlessly integrates with Microsoft Teams, providing real-time alerts, an advanced medical image viewer, and facilitating collaborative decision-making among stroke teams.
Regulatory Approvals
The Methinks Stroke Suite is CE-marked and has received multiple FDA 510(k) clearances for both its NCCT Stroke and CTA Stroke solutions, enabling its use in various healthcare settings.
Physician Tip

For physicians, Methinks Software S.L. offers a critical advantage by significantly reducing the time to stroke diagnosis and treatment, which is paramount for improving patient outcomes. The ability to detect LVOs and ICH from readily available non-contrast CT scans expands access to advanced stroke assessment, particularly in hospitals lacking specialized imaging or neuroradiology expertise. The real-time alerts and seamless integration with Microsoft Teams streamline communication and coordination among stroke teams, enabling faster, more informed decisions. This AI solution acts as a powerful triage tool, complementing clinical expertise by flagging suspected strokes and ensuring that subtle, yet critical, occlusions are not missed. Its validated performance and adherence to security standards like GDPR and HIPAA provide confidence in its reliability and data protection.

Methinks' solutions are designed for seamless integration into existing hospital systems, including PACS and Microsoft Teams, to facilitate real-time collaboration and image sharing. The company has also established strategic partnerships with major healthcare technology providers like Medtronic and Siemens Healthineers to enhance distribution, integrate with existing stroke treatment portfolios, and explore next-generation AI stroke solutions.

Products by Methinks Software S.L.

2 products in the directory

Methinks NCCT Stroke
Methinks Software S.L.
Neurology AI
Methinks NCCT Stroke is an FDA-cleared AI software that detects suspected Large Vessel Occlusions (LVOs) and intracranial hemorrhages (ICH) on non-contrast CT scans, enabling rapid stroke triage and improving patient outcomes.
Methinks CTA Stroke
Methinks Software S.L.
Neurology AI
Methinks CTA Stroke is an FDA-cleared AI software that accurately detects suspected large vessel occlusions (LVOs) from CTA scans, including distal occlusions, with high sensitivity and specificity. It integrates with hospital systems and Microsoft Teams for real-time stroke triage and team coordination.

What the Web Says

Methinks Software S.L. (operating as 'methinks') is a user research platform that facilitates qualitative research through live video interviews, surveys, and other feedback collection tools. Reviewers generally praise its ease of use, intuitive interface, and effectiveness in gathering customer insights. The company also offers an AI algorithm for healthcare, specifically for detecting large vessel occlusion (LVO) in non-contrast head CT scans, showing promise in improving LVO detection.nnAs an employer, information is limited, but employee reviews on Salary.com suggest an average hourly salary of $58 in the United States.

Overall: Positive

Strengths

  • Easy to use interface with a low learning curve.
  • Effective for user research, providing valuable insights and analytics.
  • Facilitates efficient and cost-effective qualitative research.
  • Timely payments for participants in user research gigs.
  • Responsive and transparent support staff.
  • AI algorithm shows promise in improving LVO detection in healthcare.

Limitations

  • Limited frequency of new user research gigs/opportunities.
  • User base for the research platform still needs to grow for faster turnaround times.
  • Job selection process for participants can be slow.
  • Some Reddit users reported limited opportunities and not finding the app worthwhile for earning.
  • The AI algorithm for LVO detection, while promising, has lower sensitivity than CTA-based systems, suggesting a need for further refinement.

Based on reviews from: G2, Salary.com, Reddit, B2Saas, Apple App Store, SourceForge, SoftwareSuggest, Capterra Portugal, PubMed

Last updated: 2026-07-19

Videos

News, demos, and interviews about Methinks Software S.L..

Loading videos...

Videos load interactively. If none appear, search YouTube for Methinks Software S.L. →

View all on YouTube

Press & Coverage

BioWorld
Methinks sets sights on FDA approval after CE mark win for stroke software
Methinks Software SL is preparing for U.S. FDA submission of its AI-based stroke triage software after receiving CE mark certification for its ability to detect large vessel occlusions and intracerebral hemorrhages on non-contrast CT images.
2023-03
Methinks AI
Methinks AI secures u20ac2.19M to speed neurological diagnosis in emergency departments
Methinks Software, S.L. launched Neuro-rescue, a project funded by u20ac2.19 million from the Spanish State Research Agency, to accelerate neurological diagnosis in emergency departments using AI and telemedicine.
2026-04
Methinks AI
Methinks and Siemens Healthineers have signed an agreement to explore collaboration to Deliver Next-Generation AI Stroke Solutions Worldwide
Methinks announced a collaboration agreement with Siemens Healthineers to bring innovative digital solutions for stroke management to the Southern Europe market, following Methinks' FDA clearance and a distribution agreement with Medtronic.
2025-10
Methinks AI
Methinks AI Secures Second FDA Clearance, Expanding its Stroke Detection Solution to Contrast Imaging
Methinks AI received its second FDA 510(k) clearance for Methinks CTA Stroke, an AI-based software that detects suspected large vessel occlusions using CT Angiography scans, building on its earlier clearance for non-contrast CT.
2025-10
accessdata.fda.gov
K251590 - 510(k) Premarket Notification - FDA
The FDA granted 510(k) clearance to Methinks CTA Stroke, a radiological computer-aided triage and notification software for identifying suspected Large Vessel Occlusions (LVO) in adult patients with suspected acute stroke using CT Angiography images.
2025-08
American Heart Association Journals
Deep Learning Based Software to Identify Large Vessel Occlusion on Noncontrast Computed Tomography | Stroke - American Heart Association Journals
This study analyzed the accuracy of MethinksLVO software in identifying large vessel occlusion (LVO) on noncontrast computed tomography (NCCT), demonstrating its ability to accurately predict LVO in patients with suspected acute ischemic stroke.
2020-08
American Heart Association Journals
Multicenter Validation of Artificial Intelligence Predicting Anterior Circulation Large Vessel Occlusion Using Noncontrast Head CT | Stroke: Vascular and Interventional Neurology - American Heart Association Journals
A multicenter study validated the performance of an artificial intelligence software (MethinksLVO, Methinks Software S.L., Spain) in predicting large vessel occlusion (LVO) on noncontrast computed tomography (NCCT), showing comparable performance to other deep learning algorithms.
2025-07
American Heart Association Journals
Initial Experience With a Deep Learning Algorithm for Detecting Posterior Circulation Large Vessel Occlusion on Noncontrast Computed Tomography | Stroke: Vascular and Interventional Neurology - American Heart Association Journals
A retrospective, multicenter study evaluated the diagnostic performance of a deep learning algorithm (Methinks Software S.L.) for detecting posterior circulation large vessel occlusion (PC-LVO) on noncontrast CT scans.
2026-06

Frequently Asked Questions

Methinks offers AI-powered solutions like Methinks NCCT Stroke and Methinks CTA Stroke for the early detection of large vessel occlusions and intracranial hemorrhages in stroke patients. These solutions seamlessly integrate with hospital systems such as PACS and Microsoft Teams, enabling real-time collaboration and image sharing for expedited treatment decisions.
Methinks Software S.L. has received multiple FDA 510(k) clearances for its NCCT Stroke and CTA Stroke software, allowing commercialization in the US market. Additionally, their Methinks Stroke Suite holds CE Mark certification, enabling its use in Europe.
Methinks offers flexible pricing models, including yearly, monthly, and one-time perpetual licenses, with options to customize services based on specific needs. Healthcare institutions are encouraged to contact their sales team directly for detailed pricing information and to obtain a tailored quote.
Methinks provides a dedicated customer success team to ensure optimal satisfaction and clinical workflow efficiency, offering assistance with questions, technical issues, and training needs. They also offer live chat support, blogs, and help guides for software training.
Methinks has formed significant partnerships with key industry players, including Medtronic for enhancing stroke treatment pathways in various regions and Siemens Healthineers to explore next-generation AI stroke solutions. They also collaborate with Microsoft to enhance scalability and accessibility through integration with Microsoft Teams and Azure.
Methinks Software S.L. is a venture-backed, commercial-stage digital health company founded in 2016, specializing in AI-based imaging assessment solutions for neurovascular emergencies. They have secured multiple funding rounds, including a recent u20ac2.19 million for their Neuro-rescue project, indicating ongoing investment and growth.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.